DOV-216,303
Overview[edit | edit source]
DOV-216,303 is a triple reuptake inhibitor that affects the neurotransmitter systems of serotonin, norepinephrine, and dopamine. It is primarily studied for its potential use in the treatment of major depressive disorder and other psychiatric disorders.
Mechanism of Action[edit | edit source]
DOV-216,303 functions by inhibiting the reuptake of three key neurotransmitters: serotonin, norepinephrine, and dopamine. This action increases the availability of these neurotransmitters in the synaptic cleft, which is believed to contribute to its antidepressant effects.
Serotonin Reuptake Inhibition[edit | edit source]
Serotonin is a neurotransmitter that plays a crucial role in mood regulation. By inhibiting its reuptake, DOV-216,303 increases serotonin levels, which can help alleviate symptoms of depression.
Norepinephrine Reuptake Inhibition[edit | edit source]
Norepinephrine is involved in alertness and energy. DOV-216,303's inhibition of norepinephrine reuptake can enhance these effects, potentially improving mood and cognitive function.
Dopamine Reuptake Inhibition[edit | edit source]
Dopamine is associated with pleasure and reward. By preventing its reuptake, DOV-216,303 may enhance motivation and pleasure, which are often diminished in depressive states.
Clinical Development[edit | edit source]
DOV-216,303 has been investigated in various clinical trials to assess its efficacy and safety in treating depression. The compound's ability to target three neurotransmitter systems simultaneously distinguishes it from traditional selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs).
Potential Benefits[edit | edit source]
The triple reuptake inhibition mechanism of DOV-216,303 may offer advantages over existing antidepressants by providing a more comprehensive approach to neurotransmitter modulation. This could result in improved efficacy for patients who do not respond to conventional treatments.
Side Effects[edit | edit source]
As with many psychotropic medications, DOV-216,303 may have side effects, including but not limited to insomnia, nausea, and headache. The safety profile of DOV-216,303 continues to be evaluated in ongoing research.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
